BAFF Recombinant Protein: A Key Tool for B Cell Survival Regulation and Autoimmune Disease Research
This article systematically elaborates on the molecular characteristics and biological functions of B-cell activating factor (BAFF), a member of the TNF ligand family, detailing its signaling network that regulates B-cell survival, proliferation, and differentiation through three receptors. It analyzes the pathogenic role of BAFF in autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, and explores the application strategies of BAFF recombinant proteins in B-cell function research and targeted drug development.
- Recent Advances
- Product Information
Recent Advances
BAFF Recombinant Protein: A Key Tool for Studying B Cell Survival Regulation and Autoimmune Diseases
Summary: This article systematically elaborates on the molecular characteristics and biological functions of B-cell activating factor (BAFF), a member of the TNF ligand family, and its signaling network through three receptors that regulate B cell survival, proliferation, and differentiation. It analyzes the pathological role of BAFF in autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, and discusses the application strategies of BAFF recombinant protein in B cell function research and targeted drug development.
1. Research Background of Autoimmune Diseases and B Cell-Targeted Therapies
Autoimmune diseases occur when the immune system malfunctions, leading to attacks on normal cells by autoantibodies or autoreactive lymphocytes, resulting in damage to the body's tissues and organs. There are over 100 types of autoimmune diseases, ranking as the third most common category of diseases after cardiovascular diseases and cancer. B cells, as one of the most important effector cells in autoimmune diseases, have become a focal point for drug development targeting B cell-related molecules. Among these targets, BAFF has garnered significant attention due to its central role in B cell survival and the regulation of autoimmune tolerance.
2. Molecular Characteristics and Receptor System of BAFF
B-cell activating factor (BAFF), also known as TNFSF13B or CD257, is a critical survival factor for B cells and belongs to the tumor necrosis factor (TNF) ligand family. It exists in both soluble and membrane-bound forms. BAFF is expressed on various cell types, including monocytes, dendritic cells, and bone marrow stromal cells. It binds to three receptors: TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR.
BAFF plays a key role in supporting B cell survival and proliferation, regulating class-switch recombination, and selecting autoreactive B cells through interactions with its receptors. Additionally, studies have shown that BAFF can promote T cell activation, proliferation, and differentiation. BAFFR is the primary receptor for BAFF, mainly mediating B cell survival signals. TACI exhibits more complex regulatory functions, providing both positive signals for B cell activation and negative regulation to prevent excessive activation. BCMA primarily supports the survival of long-lived plasma cells in the bone marrow. The differential expression and functional分工 of these three receptors enable BAFF to finely regulate different stages of B cell development.
3. Pathological Role of BAFF in Autoimmune Diseases
BAFF is involved in the pathogenesis of many human autoimmune diseases. Elevated serum levels of BAFF have been detected in patients with systemic lupus erythematosus (SLE), multiple sclerosis (MS), IgA nephropathy, Sjögren's syndrome, and rheumatoid arthritis (RA). Among these, SLE is a chronic systemic autoimmune disease characterized by multi-system damage. Its pathogenesis is complex, involving the proliferation and activation of autoreactive T and B cells, the production of various pathogenic autoantibodies, and abnormal cytokine secretion and receptor expression.
The mechanisms by which BAFF overexpression contributes to autoimmunity primarily involve two aspects: First, excessive BAFF supports the survival of autoreactive B cells, allowing these cells to escape immune tolerance checkpoints and ultimately leading to the production of autoantibodies and tissue damage. Second, BAFF can also promote T cell activation, proliferation, and differentiation, further amplifying immune responses through positive feedback loops. BAFF transgenic mice spontaneously develop severe autoimmune phenotypes resembling SLE and Sjögren's syndrome, further confirming BAFF's driving role in autoimmune pathology.

4. Applications of BAFF Recombinant Protein in B Cell Research
In BAFF-related basic research and drug development, high-quality recombinant BAFF protein is a core tool for elucidating its signaling mechanisms and evaluating targeted intervention strategies. Recombinant BAFF protein can be used in the following research scenarios: as a standard for establishing and validating BAFF immunoassays; as a survival factor in in vitro B cell culture systems to maintain long-term B cell survival and proliferation; for analyzing the binding activity of BAFF with BAFFR, TACI, and BCMA receptors; and for screening anti-BAFF antibody drugs.
In experimental design, the following key factors should be considered. BAFF concentration should be optimized for the experimental system to achieve optimal effects in B cell survival and proliferation assays. Buffer components should avoid substances that interfere with the stability of BAFF trimer structure. For long-term culture experiments, fresh BAFF should be replenished periodically to maintain active concentrations. Additionally, positive and negative controls should be included to validate the experimental system.
5. Conclusion
To meet the practical needs of BAFF-related research, Uni provides BAFF Protein, Mouse. This product is suitable for in vitro survival and proliferation studies of mouse B cells, binding activity analysis of BAFF with BAFFR/TACI/BCMA receptors, in vitro screening and evaluation of anti-BAFF antibody drugs, and functional studies of BAFF in autoimmune disease animal models.
As a core regulator of B cell survival and a key driver in the pathogenesis of autoimmune diseases, BAFF has become one of the most promising therapeutic targets in the field of autoimmune diseases due to its precise regulation of B cell survival, proliferation, and differentiation through three receptors. Its elevated expression in diseases such as SLE and MS, along with its close association with disease activity, provides a solid theoretical foundation for BAFF-targeted therapies. BAFF Protein, Mouse offers a reliable tool for studying BAFF signaling pathways and developing targeted drugs, driving innovation in the treatment of autoimmune diseases.
Product Information







